Complex delivery of water-bound content through this system allows for smaller technologies to penetrate the skin
Stop use and consult a healthcare provider if you experience severe allergic reactions (difficulty breathing, significant swelling, hives spreading beyond the injection site), chest pain or palpitations, severe or persistent gastrointestinal symptoms, or any symptom that concerns you significantly
Your provider determines the schedule based on your labs and response
Chang E, Weinstock C, Zhang L, Charlab R, Dorff SE, Gong Y, Hsu V, Li F, Ricks TK et al (2021) fda approval summary: enfortumab vedotin for locally advanced or metastatic urothelial carcinoma FDA approval summary: enfortumab vedotin
These researchers discovered that castration caused 4-hydroxynonenal and 8-hydroxy-20-deoxy-guanosine protein adducts in the regressing epithelium, which suggests oxidative damage